Organon Canada Announces Availability Of NDUVRA To Treat Moderate To Severe Atopic Dermatitis

Organon Canada has announced the approval and availability of NDUVRA® (tapinarof cream), 1%, for the treatment of moderate to severe atopic dermatitis in adults and children aged 2 years and older. This new product expands the company's portfolio in dermatological treatments.